Biopsy proven fibroadenoma
Biopsy proven invasive ductal carcinoma with multiple satellite lesions
Dense tissue - normal duct
Extremely dense tissue - normal study
IDC grade 2 lesion with mammography
Multi-focal biopsy proven invasive ductal carcinoma
Multiple fibroadenomas
Invenia ABUS 2.0 can improve early detection
Clinical impact
Read the SomoInsight Study to learn about the effectiveness of ABUS for supplemental breast screening.
Cancer detection improves for women with dense breasts when Automated Breast Ultrasound screening is combined with 3D tomosynthesis.
Mammography plus Automated Breast Ultrasound (ABUS) results can improve earlier detection of breast cancer.
Automated Breast Ultrasound clarifies diagnosis of subareolar mass in dense breast.
Surgeon use of 3D Automated Breast Ultrasound (ABUS): The dense breast screening tool and its potential role for preoperative staging.
Economic impact
Commercial reimbursement and utilization for Invenia ABUS (Automated Breast Ultrasound).
Real World Experience and Outcomes with Invenia ABUS Imaging For Women.
Real World Experience and Outcomes with Invenia ABUS at Fort Jesse's Imaging Center and Gale Keeran Center for Women
Webinars
Developing a personalized breast screening program
Dr. Joseph Russo, Section Chief of Women's Imaging, St. Luke's University Health Network, Bethlehem, PA
Learn MoreDense breast tissue: Status of ultrasound for breast cancer screening
Marc F Inciardi, MD, Assistant Professor of Radiology, Section Head, Breast Imaging, University of Kansas Medical Center
Learn MoreImplementation of ABUS in the community setting
Monica H Saini MD, MS, Breast Radiologist
Learn MoreAutomated breast sonographic coronal imaging: Diagnostic and screening applications
Beverly E Hashimoto, MD, FACR, Section Head, Ultrasound, Virginia Mason Medical Center, Seattle, WA
Learn MoreIntroduction to Automated Breast Ultrasound Screening women with dense breasts
Dr. Monica Saini, MD, CMO for Institute of Women’s Imaging and Medical Director for ABUS at GE Healthcare
Learn MoreCase review and clinical discussion of the clinical effectiveness of 3D ABUS at ECR 2018
Athina D. Vourtsis MD, PhD, Director and Founder of Diagnostic Mammography Center, Athens, Greece
Learn MoreBreast anatomy, 2D, 3D, and Automated Breast Ultrasound
Mary Henne, MS, CNMT, RDMS, RVT, Clinical Research Education Leader - ABUS and Beverly E Hashimoto, M.D., FACR, Section Head, Ultrasound, Virginia Mason Medical Center, Seattle, WA
Learn MoreWhat are clinicians and patients saying about their experience with ABUS?
The clinical need for ABUS
How does ABUS benefit surgeons?
What should be done for patients with dense breasts?
Invenia ABUS patient experience
Product Videos
Invenia ABUS 2.0 acquisition demonstration
Invenia ABUS 2.0 overview
Invenia ABUS 2 cleaning demonstration
Invenia ABUS 2.0 patient exam demonstration
Resources
Marketing
Our dedicated support team is available to help you implement your ABUS program and make it a success. Users receive guidance and best practices, including real-world samples and professionally designed templates. Users also receive recommendations for educating key audiences, workflow options and marketing strategies help you launch your ABUS program.
Invenia ABUS 2.0 system consumable supplies
GE Healthcare offers an array of consumable supplies for the Invenia™ ABUS 2.0 and somo•v™ ABUS (Automated Breast Ultrasound) Platinum systems including scan membranes, Polysonic® ultrasound lotions, and Protex™ disinfectants. For a complete list of ABUS 2.0 accessories, visit: www.services.gehealthcare.com
Services
GE Healthcare's AssurePoint Service offering helps enhance the overall total value of ownership of your Invenia ABUS 2.0.
Educating Patients
Early detection of breast cancer enables treatment to be started earlier in the course of the disease, possibly before it has spread. Encourage your patients with dense breasts to advocate for their health and learn more about ABUS. Use the GE Healthcare ABUS Locator tool to find a facility in their area, and direct them to the website, pamphlet and video below.
Reimbursement
GE Healthcare is pleased to offer providers coding and reimbursement support:
Toll-free phone number: 1-844-386-0099
Email: GEABUS@emersonconsultants.com
Visit our reimbursement website
GE Healthcare agrees to abide by the provisions of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and any other relevant state or federal privacy laws and regulations concerning the use and/or disclosure of protected health information during the course of providing this support. CPT CODES are copyrighted by the American Medical Association.
1. Mandelson et al. J Natl Cancer Inst 2000; 92:1081–1087.
2. Tagliafico, Massimo Calabrese et al, Journal of Clinical Oncology 2016 34:16, 1882-1888.
3. Brem et al, Radiology, March 2015.
4. Pisano et al. NEJM 2005; 353: 1773.
5. Engmann NJ, et al, JAMA Oncol. 2017;3(9):1228-1236
6. Boyd NF et al. Mammographic Density and the Risk and Detection of Breast Cancer. NEJM 2007; 356: 227-36.
7. Arora N, King TA, Jacks LM., Ann Surg Onc, 2010; 17:S211-18.